מלזיה - אנגלית - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

allergan malaysia sdn bhd - brimonidine tartrate; timolol maleate -

מלזיה - אנגלית - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

allergan malaysia sdn bhd - bimatoprost; timolol maleate -

מלזיה - אנגלית - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

allergan malaysia sdn bhd - gatifloxacin -

מלזיה - אנגלית - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

allergan malaysia sdn bhd - brimonidine tartrate -

האיחוד האירופי - אנגלית - EMA (European Medicines Agency)

allergan pharmaceuticals ireland - bimatoprost, timolol - glaucoma, open-angle, ocular hypertension - ophthalmologicals, - reduction of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

האיחוד האירופי - אנגלית - EMA (European Medicines Agency)

allergan pharmaceuticals international ltd - pancreas powder - exocrine pancreatic insufficiency - digestives, incl. enzymes - pancreatic enzyme replacement treatment in exocrine pancreatic insufficiency due to cystic fibrosis or other conditions (e.g. chronic pancreatitis, post pancreatectomy or pancreatic cancer).enzepi is indicated in infants, children, adolescents and adults.

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

amo australia pty limited (nz) - disodium edetate dihydrate 0.01%; sodium chloride 0.9%;  ;  ; thiomersal 0.00115% - contact lens solution - active: disodium edetate dihydrate 0.01% sodium chloride 0.9%     thiomersal 0.00115%

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - alimemazine tartrate - oral tablet - 10mg

ארצות הברית - אנגלית - NLM (National Library of Medicine)

allergan, inc. - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - assisted reproductive technology crinone 8% is indicated for progesterone supplementation or replacement as part of an assisted reproductive technology ("art") treatment for infertile women with progesterone deficiency. secondary amenorrhea crinone 4% is indicated for the treatment of secondary amenorrhea. crinone 8% is indicated for use in women who have failed to respond to treatment with crinone 4%. crinone should not be used in individuals with any of the following conditions: - known sensitivity to crinone (progesterone or any of the other ingredients) - undiagnosed vaginal bleeding - liver dysfunction or disease - known or suspected malignancy of the breast or genital organs - missed abortion - active thrombophlebitis or thromboembolic disorders, or a history of hormone-associated thrombophlebitis or thromboembolic disorders crinone ® 4% and crinone ® 8% ("kri-noan") (progesterone gel) for vaginal use only you will need the following supplies: see figure a. step 1.  remove the applicator from the sealed wrapper. - open the sealed wrapper and remove the applicator. do not remove the twist-off cap at this time. see figure b. step 2. insert the plunger into the open end of the applicator. see figure c.   - hold the applicator on each side and push the plunger into the applicator until the plunger snaps into place. - you will see about 1 inch of the plunger outside of the applicator. step 3. remove the cap. see figures d and e. - remove the cap from the tip of the applicator by twisting it counterclockwise.  - do not push the plunger while you are removing the cap. this could cause some gel to come out. step 4. prepare to insert the applicator. see figure f. choose the position that is most comfortable for you. for example, lying down on your back with your knees bent. step 5. insert the applicator. see figure g. - after you are in a comfortable position, gently insert the rounded tip of the applicator into your vagina. step 6. push the plunger. see figure h. - while the applicator is inserted in your vagina, push the plunger to release the gel into your vagina. step 7. remove the applicator from your vagina and throw it away in your household trash. - it is normal for a small amount of gel to be left in the applicator. you will still get the right dose of medicine. this instructions for use has been approved by the u.s. food and drug administration. rx only for all medical inquiries contact: allergan usa, inc. irvine, ca 92612 1-800-678-1605 distributed by: allergan usa, inc. irvine, ca 92612 content updated: june 2017 © 2017 allergan. all rights reserved. crinone® is a registered trademark of allergan sales, llc. allergan® and its design are trademarks of allergan, inc. product of the netherlands. 73343us10

סינגפור - אנגלית - HSA (Health Sciences Authority)

abbvie pte. ltd. - ophthalmology - soothing relief for dry, irritated eyes.